Relmada Therapeutics, Inc.

RLMD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2013

Total Assets: $3.6M

Liabilities Breakdown FY2013

Total Liabilities: $21.6M